Effects of the permeability characteristics of different polymethacrylates on the pharmaceutical characteristics of verapamil hyhdrochloride-loaded microspheres

References

• AMMAR, H. 0. and KHALIL, R. M., 1997, Preparation and evaluation of sustained release solid dispersions of drugs with Eudragit polymers. Drug Development and Industrial Pharmacy, 23, 1043–1054.
   Google Scholar
• BARKAI, A., PATHAK, Y. V. and BENITA, S., 1990, Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. I. Formulation design and process optimisation. Drug Development and Industrial Pharmacy, 16, 2057–2075.
   Web of Science ®Google Scholar
• BENOIT, J. P. and MARCHAIS, H., 1996, Biodegredable microspheres: advances in production technology. In Microencapsulation, Methods and Industrial Applications, edited by S. Benita (New York: Marcel Dekker).
   Google Scholar
• BOGATAJ, M., MAHAR, A., GRABNAR, I., RAJTMAN, Z., BUKOVEC, P., SRCIC, S. and URLEB, U., 2000, The influence of magnesium stearate on the characteristics of mucoadhesive microspheres. Journal of Microencapsulation, 17, 499–508.
   PubMedGoogle Scholar
• BROGDEN, R. N. and BENFIELD, P., 1996, Verapamil, a review of its pharmacological properties and therapeutic use in coronary artery disease. Drugs, 51, 792–819. Catalog of Rohm Pharma GmbH, Eudragit Data Sheets, Industrial Products Division, Weiterstadt.
   Google Scholar
• DAS, S. K. and DAS, N. G., 1998, Preparation and in vitro dissolution profile of dual polymer (Eudragit RS 100 and RL 100) microparticles of diltiazem hydrochloride. Journal of Microencapsulation, 15, 445–452.
   PubMedGoogle Scholar
• DASHEVSKY, A. and ZESSIN, G., 1997, The effect of ethylcellulose molecular weight on the properties of theophylline microspheres. Journal of Microencapsulation, 14, 273–280.
   PubMedGoogle Scholar
• FOLLONIER, N. and DOELKER, E., 1992, Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. S.T.P. Pharma Sciences, 2, 141–158.
   Google Scholar
• GIBALDI, M. and FELDMAN, S., 1967, Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to non-disintegrating dosage forms. Journal of Pharmaceutical Sciences, 56, 1238–1242.
   PubMedGoogle Scholar
• GIUNCHEDI, P., CONTE, U., MAGGI, L. and LA MANNA, A., 1992, Hydropilic matrices for the extended release of a model drug exhibiting pH-dependent solubility. International Journal of Pharmaceutics, 85, 141–147.
   Google Scholar
• GORACINOVA, K., KLISAROVA, L. and Slimy, A., 1995, Physical characterization and dissolution properties of verapamil HC1 coprecipitates. Drug Development and Industrial Pharmacy, 21, 383–391.
   Google Scholar
• GOTO, S., KAWATA, M., NAKAMURA, M., MAEKAWA, K. and AOYAMA, T., 1986a, Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen. Journal of Microencapsulation, 3, 293–304.
   PubMedGoogle Scholar
• GOTO, S., KAWATA, M., NAKAMURA, M., MAEKAWA, K. and AOYAMA, T., 1986b, Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofen. Journal of Microencapsulation, 3, 305–316.
   PubMedGoogle Scholar
• GOTO, S., KAWATA, M., NAKAMURA, M., NAGATSUMA, Y., FUJINAGA, K. and AOYAMA, T., 1988, Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs. Journal of Microencapsulation, 5, 343–360.
   PubMedGoogle Scholar
• HAMANN, S. R., BLOUMIN, R. A. and McALLISTER, JR, R. G., 1984, Clinical pharmacokinetics of Verapamil. Clinical Pharmacokinetics, 9, 26–41.
   PubMedGoogle Scholar
• HIGUCHI, T., 1963, Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drug dispersed in solid matrices. Journal of Pharmaceutical Sciences, 52, 1145–1149.
   PubMed Web of Science ®Google Scholar
• HUANG, H.P. and GHEBRE-SELLASIE, I., 1989, Preparation of microspheres of water-soluble pharmaceuticals. Journal of Microencapsulation, 6, 219–225.
   Google Scholar
• KARim, A. and PIERGIES, A., 1995, Verapamil stereoisomerism: Enantiomeric ratios in plasma depedent on peak concentrations, oral input rate, or both. Clinical Pharmacology and Therapeutics, 58, 174–184.
   PubMedGoogle Scholar
• KAWATA, M., NAKAMURA, M., GOTO, S. and AOYAMA, T., 1986, Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen. Chemical Pharmaceutical Bulletine, 34, 2618–2623.
   PubMedGoogle Scholar
• KIBBE, A.H., 2000, Handbook of Pharmaceutical Excipients (Washington, DC: American Pharmaceutical Association and Pharmaceutical Press).
   Google Scholar
• KiLicARSLAN, M. and BAYKARA, T., 2003, The effect of the drug/polymer ratio on the properties of the verapamil HC1 loaded microspheres. International Journal of Pharmaceutics, 252, 99–109.
   PubMedGoogle Scholar
• KIM, C.K., KIM, M.J., OH, K.H., 1994, Preparation and evaluation of sustained release microspheres of terbutaline sulfate. International Journal of Pharmaceutics, 106, 213–219.
   Google Scholar
• KiSLALlOGLU, M.S., KHAN, M.A., BLOUNT, C., GOETTSCH, R.W. and BOLTON, S., 1991, Physical characterization and dissolution properties of Ibuprofen: Eudragit coprecipitates. Journal of Pharmaceutical Sciences, 80, 799–804.
   PubMedGoogle Scholar
• LANGENBUCHER, F., 1972, Linearization of dissolution rate curves by the Weibull distribution. Journal of Pharmaceutics and Pharmacology, 24, 979–981.
   PubMedGoogle Scholar
• LEHMANN, K.O.R., 1997, Chemistry and application properties of polymethacrylate coating systems. In Aqueous Polymeric Coating for Pharmaceutical Dosage Forms, edited by J.W. McGinity (New York: Marcel Dekker).
   Google Scholar
• McTAvisH, D. and SORKIN, E.M., 1989, Verapamil, an updated review of its pharmacokinetic properties, and therapeutic use in hypertension. Drugs, 38, 19–76.
   PubMedGoogle Scholar
• PERUMAL, D., 2001, Microencapsultion of ibuprofen and Eudragit RS 100 by the emulsion solvent diffusion technique. International Journal of Pharmaceutics, 218, 1–11.
   PubMed Web of Science ®Google Scholar
• PONGPAIBUL, BY., PRICE, J.C. and WHITWORTH, 1984, Preparation and evaluation of controlled release mdomethacin microspheres. Drug Development and Industrial Pharmacy, 10, 1597–1616.
   Google Scholar
• PONGPAIBUL, Y. and WHITWORTH, C.W., 1986, Preparation and in vitro dissolution characteristics of propranolol microcapsules. International Journal of Pharmaceutics, 33, 243–248.
   Google Scholar
• RAWLE, A. F., 1993, The importance of particle size analyses in the pharmaceutical industry. Malvern Instruments Application Note Number MRK 125–02.
   Google Scholar
• SOPPIMATH, KS., KULKARNI, A.R. and AMINABHAVI, TM., 2001, Encapsulation of antihypertensive drugs in cellulose-based matrix microspheres: characterization and release kinetics of microspheres and tableted microspheres. Journal of Microencapsulation, 18, 397–409.
   PubMedGoogle Scholar
• US Phamacopoeia 24, 2000 (Rockville: US Pharmacopeial Convention).
   Google Scholar
• VACHON, M.G. and NAIRN, J.G., 1995, Physico-chemical evaluation of acetylsalicylic acid-Eudragit RS 100 microspheres prepared using a solvent-partition method. Journal of Microencapsulation, 12, 287–305.
   PubMedGoogle Scholar
• WATTS, P.J., DAVIES, M.C. and MELIA, C.D., 1991, Encapsulation of 5-aminosalicylic acid into Eudragit RS microspheres and modulation of their release characteristics by use of surfactants. Journal of Controlled Release, 16, 311–318.
   Web of Science ®Google Scholar
• WINGARD, B.L., BRODY, TM., LARNER, J. and SCHWARTZ, A., 1991, Human Pharmacology Molecular to Clinical: Calcium Antagonists (London: Wolfe).
   Google Scholar
• YüKsEL, N. and BAYKARA, T., 1996a, Interaction between nicardipine hydrochloride and polymeric microspheres for a controlled release system. International Journal of Pharmaceutics, 140, 145–154.
   Google Scholar
• YüKsEL, N. and BAYKARA, T., 1996b, Preparation and evaluation of controlled release microspheres containing nicardipine hydrochloride. International Journal of Pharmaceutical Advances, 1, 398–407.
   Google Scholar
• YUKSEL, N. and BAYKARA, T., 1997, Preparation of polymeric microspheres by the solvent evaporation method using sucrose stearate as a droplet stabilizer. Journal of Microencapsulation, 14, 725–733.
   PubMedGoogle Scholar
• YOKsEL, N., DINC, E., ONUR, F. and BAYKARA, T., 1998, Influence of swelling degree on release of nicardipine hydrochloride from acrylic microspheres prepared by solvent evaporation method. Pharmaceutical Development and Technology, 3, 115–121.
   PubMedGoogle Scholar
• YOKsEL, N., TURKoCLu, M. and BAYKARA, T., 2000, Modelling of the solvent evaporation method for the preparation of controlled release acrylic microspheres using neural networks. Journal of Microencapsulation, 17, 541–551.
   PubMedGoogle Scholar